EUCAST News
Here you can find the latest news and updates from EUCAST.
Interpretation of breakpoints for antifungal agents when definitions of S, I and R have changed - publication in CMI.
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).Arendrup et al.Clin Microbiol...[more]
Public consultation on piperacillin-tazobactam breakpoints and meningitis breakpoints.
There are proposed changes to piperacillin-tazobactam breakpoints for Enterobacterales. There are proposed breakpoints for bacterial meningitis. Both are now open for general consultation 17 July - 15 September, 2020.[more]
Oral cephalosporins and Enterobacterales breakpoints - updated guidance document.
Oral cephalosporins and Enterobacterales breakpoints - updated guidance document. [more]
SOP 9 revised (9.2) and SOP 11.0 published.
SOP 9 (on determining disk diffusion breakpoints and QC criteria) and SOP 11.0 (on determining the disk content/potency). [more]
Ceftolozane-tazobactam disk criteria for H. influenzae
Ceftolozane-tazobactam zone diameter breakpoints for H. influenzae now available. as an addendum to the EUCAST breakpoint table 10.0. The zone diameter breakpoints will be included in the regular breakpoint table 11.0. [more]
S.pneumoniae (10 strains) with reference MICs now available from EUCAST/CCUG.
EUCAST and CCUG in collaboration have made a panel of 10 strains with reference MICs available. Strains were selected on the basis of the varying susceptibility to betalactam agents. [more]
